Hamilton Lane Incorporated (HLNE) Price Target Lowered to $150 at UBS

Hamilton Lane Incorporated (NASDAQ:HLNE) is among the 10 Stocks That Could Skyrocket in 2026.

On February 20, UBS lowered the firm’s price target on Hamilton Lane Incorporated (NASDAQ:HLNE) to $150 from $184 while maintaining a Buy rating, reflecting broader alternative asset manager multiple compression rather than company-specific deterioration.

Previously, on February 4, Oppenheimer raised its price target on Hamilton Lane Incorporated (NASDAQ:HLNE) to $230 from $220 and reiterated an Outperform rating, citing strong Q3 performance. Although the stock retraced gains amid broader credit-related concerns across the alternatives sector, Oppenheimer characterized such concerns as misplaced. On February 3, Hamilton Lane reported fiscal year-to-date GAAP EPS of $4.35 and non-GAAP EPS of $4.41, and declared a quarterly dividend of $0.54, consistent with a targeted $2.16 for FY2026, representing a 10% year-over-year increase.

Hamilton Lane Incorporated (NASDAQ:HLNE) also closed its partnership with Guardian, under which it will oversee nearly $5 billion of Guardian’s private equity portfolio and expects approximately $500 million of additional annual commitments for at least a decade, including at least $250 million directed to HL Evergreen, with minimal dilution. These developments strengthen fee-related earnings visibility and long-term AUM growth prospects.

Hamilton Lane Incorporated (NASDAQ:HLNE) was founded in 1991 and is headquartered in Conshohocken, Pennsylvania. It is a global alternative investment management and advisory firm specializing in private markets solutions for institutional and retail investors. Its expanding platform, durable client relationships, and growing evergreen structures support sustained earnings and dividend growth potential.